Searchable abstracts of presentations at key conferences in endocrinology

ea0065p154 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Checkpoint inhibitors and immune related diabetes mellitus: a case series

Hanafy Ahmed , Seejore Khyatisha , Kyriakakis Nikolaos , Al-Qaissi Ahmed , Kassim Saifuddin , Marples Maria , Murray Robert D

Introduction: Checkpoint inhibitors (CPi) are finding a place in the treatment algorithm of an increasing number of cancers. Immune-related (ir) endocrinopathies are frequent side-effects. Diabetes mellitus (irDM) is infrequent, but often presents acutely and can be potentially life-threatening There are ˜60–70 cases characterising irDM in the literature. We describe 4 cases of irDM to add to the understanding of this condition. All four patients were undergoing trea...

ea0038p121 | Clinical practice/governance and case reports | SFEBES2015

A case of morning headache: Doege–Potter syndrome

Kassim Saifuddin , Pillai Anita , MacInerney Ruth , Vanheeswijk Isabelle , Harsimar Jhittay , Robinson Emma

Tumour induced hypoglycaemia is a rare disorder occurring in cancer patients caused by variety of tumours including islet and non-islet tumours. Non-islet cell tumour induced hypoglycaemia (NICTH) is rare paraneoplastic disorders normally associated with pleural solitary fibrous tumour but can also rarely occur in extra thoracic site.We describe an 86-year-old man not known to have diabetes mellitus who presented with 3-month history of early morning hea...

ea0032p218 | Clinical case reports – Pituitary/Adrenal | ECE2013

Hypopituitarism and pituitary masses in patients with non-pituitary malignancy

Kassim Saifuddin , Wright Josh , Foran Bernie , Sinha Saurabh , Newell-Price John , Ross Richard

The commonest cause of acquired hypopituitarism is a benign pituitary adenoma. However, in patients with non-pituitary malignancy different diagnoses need to be considered. We describe three oncology patients presenting with hypopituitarism and/or a pituitary mass where the cause was related either to malignant disease or its treatment.Case 1: A 56-year-old man with known metastatic melanoma presented with increasing lethargy. Investigation showed a larg...

ea0090p288 | Adrenal and Cardiovascular Endocrinology | ECE2023

Symptoms and Steroid Dose Adjustments Associated with the SARS-CoV-2 Vaccine in Patients with Adrenal Insufficiency

McLaren David , Crowe Grace , Cassidy Christine , Rasool Irum , elsabbagh mohamed , Eyadeh Ahmad , Poe Poe Han Htwe Nang , Gerrard Melinda , Ward Emma , Kassim Saifuddin , Abbas Afroze , Al-Qaissi Ahmed , M Orme Steve , Seejore Khyatisha , Kyriakakis Nikolaos , Maguire Deirdre , Lynch Julie , D Murray Robert

Background: Following vaccination for SARS-CoV-2 a significant proportion of individuals experience moderate to severe symptoms. In patients with adrenal insufficiency (AI) this has been reported to translate in to need for increased glucocorticoids and incipient or frank adrenal crises. We assessed occurrence of symptoms, need for glucocorticoid dose adjustment and crises in a large cohort of patients with AI following vaccination for SARS-CoV-2.Methods...